… for the analysis of imazethapyr, IgG, digoxin… LC-MS/MS to identify biomarkers for diabetic
nephropathy in human plasma[141], and multi-lectin columns have been utilized in the analysis …

… LC-MS/MS … biosimilar mAbs are becoming available for a single originator drug, so it is
critical to demonstrate their similarity with the reference product to ensure its quality characteristics…

… Using proximity dependent labeling coupled to LC-MS/MS, … concentrator prior to LC-MS/MS
analysis. Dried peptides were … Biosimilars will maintain momentum in a highly competitive …

… mass tag (TMT) reagents followed by LC-MS/MS analysis. Their strategy was able to identify
… Stewart and colleagues in 2019 used an antibody-based phosphoproteomic platform to …

… To counteract the ‘biosimilars effect’, pharmaceutical … To assess the efficacy of the supernatants
of the miniaturized and … all the peptides detected in the LC-MS/MS analysis. The results …

… (SDS-PAGE) and nano-LC/MS/MS. In a subsequent study, … Using proteomics analysis to
study the effect of ranibizumab … Generic biosimilars of ranibizumab have faced complications, …

… and accessibility in glycosylation analysis, emphasizing the … the S-trap protocol (mini) according
to manufacturer’s … demonstrated through its application to two additional therapeutic IgG …

… In addition, the main assay methods that can be applied for the characterization of
PEGylated molecules in complex biological samples are also summarized in this paper. …

… In biomolecules analysis, the bioactivity and bio-affinity analysis is a very important part
during the formulation efficacy and stability study, and the organic solvents are not compatible …